Literature DB >> 2106005

Serial passage of west-European sporadic non-A non-B hepatitis in rhesus monkeys by inoculation with fecal extracts.

M D Sharma1, P Maillard, S Vrati, R Mukherjee, M S Rajagopalan, T Poynard, G P Talwar, J Pillot.   

Abstract

An experimental model of sporadic non-A non-B hepatitis involving a Fab nonimmune binding activity in stools was established in the rhesus monkey. The first animal was inoculated intravenously with a stool extract from a French patient who had never left the country and in whom post-transfusion hepatitis was excluded. Four passages were performed, and the infection was transmitted by parenteral as well as the oral routes by inoculation of stools or liver extracts. Infection led in three monkeys to reversible hepatocyte injury manifested by a transitory increase in serum aminotransferases. The other three animals, in which persistently high levels of aminotransferases was observed, were sacrificed on day 60 after inoculation. The incubation period, as evidenced by elevation of aminotransferases was about 3 to 4 weeks. The infectious agent was transitorily present in the stools before aminotransferase elevation. The presence of the infectious agent in the stools was correlated with the nonimmune Fab binding activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106005     DOI: 10.1002/jmv.1890300108

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  A B C d e f g ...

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1996-05

2.  An epidemic of non-A, non-B hepatitis in south Delhi: epidemiological studies and transmission of the disease to rhesus monkeys.

Authors:  S Vrati; D K Giri; S K Parida; G P Talwar
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Isolation of the novel agent from human stool samples that is associated with sporadic non-A, non-B hepatitis.

Authors:  N Deka; M D Sharma; R Mukerjee
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.